1.Study on bacterium casing community - accquired pneumonia in respiratory department in Bach Mai hospital
Journal of Practical Medicine 2005;0(12):4-6
Investigation on 257 patients with community-accquired pneumonia in respiratory deparment in Bach Mai hospital from 1/2002to 6/2003 showed that: 56% patients had test of bacterium; 38,9% of them found bacterium that caurse disease. About 80% patients catch negative Gram; 20% catch positive Gram. Bacteriums found with the highest rate were: S.pneumoniae (17%); K.pneumoniae (25,4%); P.aeruginosa (22,4%). The research also studied antibiotics resistant of that bacteriums.
Bacteria
;
Pneumonia
;
Community-Acquired Infections
2.Evaluation of the clinical efficacy and safety of clarithromycin in treament of community acquired pneumonia
Journal Ho Chi Minh Medical 2004;8(1):22-27
Clarithromycin had high efficacy in treatment of 39 community acquired pneumonia with low risk factors, including pneumonia 38 patients (50.67%), exacerbation of COPD and asthma 24 patients (32%), and acute bronchitis due to bacteria 13 patients (17.33%), with succesfully rate of 95.65%. The average duration of therapy was 8.56 days and only a few side effects (5.8%), including mainly nausea and diarrhea were observed. Clarithromycin is a safe and effective drug in treatment of community acquired lower respiratory infections
Pneumonia
;
Clarithromycin
;
Therapeutics
;
Pharmaceutical Preparations
;
Community-Acquired Infections
3.Changes in the epidemiology and burden of community-acquired pneumonia in Korea.
The Korean Journal of Internal Medicine 2014;29(6):735-737
No abstract available.
Community-Acquired Infections/*epidemiology
;
Female
;
Humans
;
Male
;
Pneumonia/*epidemiology
7.Changes in the pathogen spectrum of hospitalized adults with community-acquired pneumonia in Fujian Province: A multicenter, retrospective study from 2012 to 2018.
Fan WU ; Jian WU ; Nengluan XU ; Qunying LIN ; Dongfa QIU ; Xuhua LYU ; Ming LIN ; Wenxiang YUE ; Yan XIAO ; Lili REN ; Yusheng CHEN ; Hongru LI
Chinese Medical Journal 2023;136(8):989-991
8.An Outbreak of Community Associated Methicillin Resistant Staphylococcus aureus Subtype USA300 at an International School in Singapore.
Dixon GRANT ; Tse Hsien KOH ; Yen Ee TAN ; Li Yang HSU ; Asok KURUP ; Shelly K DONAHUE ; Janelle MANN ; Dale FISHER
Annals of the Academy of Medicine, Singapore 2013;42(11):575-578
Community associated methicillin-resistant Staphylococcus aureus (CA-MRSA) subtype USA300 remains relatively well confined within North American shores. Between August and November 2010, a large international school in Singapore recorded 27 skin and soft tissue infections, 8 of which were confirmed USA 300. This study reports the outbreak investigation and the interventions instituted.
Community-Acquired Infections
;
Disease Outbreaks
;
Humans
;
Methicillin
;
Methicillin-Resistant Staphylococcus aureus
;
Singapore
;
Staphylococcal Infections
;
epidemiology
;
Staphylococcal Skin Infections
9.Respiratory Review of 2010: Pneumonia.
Tuberculosis and Respiratory Diseases 2010;68(6):319-327
Pneumonia represents a spectrum of diseases that range from community-acquired to health care-associated pneumonia. Despite advances in diagnosis, antimicrobial therapy, and supportive care, pneumonia remains an important cause of morbidity and mortality, particularly in elderly patients and in those with significant comorbidities. Community-acquired pneumonia (CAP) is the leading cause of death from infectious disease in Korea. This article provides a synopsis of recent studies regarding various types of pneumonia, with a focus on CAP.
Aged
;
Cause of Death
;
Communicable Diseases
;
Community-Acquired Infections
;
Comorbidity
;
Humans
;
Korea
;
Pneumonia
10.Reduning injection for community-acquired pneumonia: meta-analysis.
Wanpeng GAO ; Shiguang WANG ; Zhuang CUI ; Jie CAO ; Hengyong TIAN
China Journal of Chinese Materia Medica 2011;36(24):3539-3543
OBJECTIVETo evaluate the efficacy and safety of Reduning injection for treating community-acquired pneumonia.
METHODLiteratures about randomized controlled trials of Reduning injection for treating community-acquired pneumonia were reviewed. The methodological quality of the trials was assessed by the Jadad scale, and evaluation was performed.
RESULTSeven RCTS were included. Reduning combined group (Reduning injection plus antibiotics and basic therapy) was compared with antibiotics group (antibiotics plus basic therapy). Meta-analysis showed that the relative risk (RR) for the total cure rate was 1.34, and 95% confidence interval (CI) was [1.19, 1.51]; RR for the total effective rate was 1.10, and 95% CI was [1.06, 1.15]. The weighted mean difference (WMD) in disappearance time of fever between the two groups was - 1.42, and 95% CI was [- 2.58, -0.26]; The WMD between the two groups for the total obvious effect rate of cough and expectoration were - 2.36, and 95% CI was [- 3.41, - 1.31]; Improve the time of pulmonary rales MD -2.30, 95% CI [- 2.61, - 2.00]; The WMD between the two groups in absorption of chest x-ray shadow was -2.36 and 95% CI [-2.52, -2.20]. Serious systematic adverse reactions had not been reported in the trials.
CONCLUSIONThe effect of combined therapy with Reduning injection plus antibiotics and basic therapy is better than that of antibiotics plus basic therapy. Reduning injection can improve the symptoms of cough and expectoration, shorten the fever time and facilitate the absorption of chest x-ray shadow without any significant adverse reactions. However, further high quality trials are needed.
Community-Acquired Infections ; drug therapy ; Drugs, Chinese Herbal ; therapeutic use ; Humans ; Injections ; Pneumonia ; drug therapy